BRD7 Antibody

說明書

中文名稱：

BRD7兔多克隆抗體
貨號：

CSB-PA002803GA01HU
規(guī)格：

￥3,900
其他：

產(chǎn)品詳情
產(chǎn)品評價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

Uniprot No.：

Q9NPI1
基因名：

BRD7
別名：

75 kDa bromodomain protein antibody; BP75 antibody; BRD 7 antibody; BRD7 antibody; BRD7_HUMAN antibody; Bromodomain containing 7 antibody; bromodomain containing protein 7 antibody; Bromodomain-containing protein 7 antibody; CELTIX 1 antibody; CELTIX1 antibody; NAG4 antibody; Protein CELTIX-1 antibody
宿主：

Rabbit
反應(yīng)種屬：

Human,Mouse
免疫原：

Human BRD7
免疫原種屬：

Homo sapiens (Human)
抗體亞型：

IgG
純化方式：

Antigen Affinity Purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB
Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

功能：

Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR. Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase.
基因功能參考文獻(xiàn)：
1. the transcriptional signature of low BRD7 expressing cells is associated with increased angiogenesis. PMID: 28951988
2. our data indicated that BRD7 may serve as a tumor suppressor in hepatocellular carcinoma PMID: 26919247
3. Results demonstrate a novel function of BRD7 in TGF-beta signaling. BRD7 interacts with the Smad tumor suppressor complex, and enhances both DNA-binding ability and transcriptional activity of Smads. BRD7 functions in growth inhibition and tumor suppression partly as a transcriptional co-activator of Smads. PMID: 27270427
4. Overexpression of BRD7 inhibited cyclin D and myc expression. Our findings are consistent with a tumor suppressor role for BRD7 in lung adenocarcinoma tumorigenesis. PMID: 27580131
5. the expression of miR-141 in BRD7-overexpressing NPC cells could partially reverse the tumor suppressive effect of BRD7 on cell proliferation and tumor growth in vitro and in vivo. PMID: 27010857
6. constructed a regulating network of BRD7 downstream genes, and this network suggests multiple feedback regulations of the pathways. Furthermore, we validated BIRC2, BIRC3, TXN2, and NOTCH1 genes as direct, functional BRD7 targets PMID: 26407966
7. Propose that the balance between BRD7 function and Ras/Raf/MEK/ERK activity is important for determining the outcomes of HCV infection and HCC development. PMID: 26620707
8. Ectopic expression of BRD7 could significantly inhibit miR-300-promoted proliferation, invasion and epithelial-mesenchymal transition in osteosarcoma. PMID: 26010572
9. BRD7 promoter hypermethylation is an indicator of well differentiated oral squamous cell carcinomas. PMID: 25743841
10. Data indicate that bromodomain-containing protein 7 (BRD7) was a direct target of microRNA-410 (miR-410). PMID: 26149213
11. lower BRD7 expression is an indicator for poor prognosis in patients with osteosarcoma. PMID: 24840027
12. These results suggested that BRD7 acts as a tumor suppressor in epithelial ovarian cancers PMID: 24198243
13. Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. PMID: 24404152
14. BRD7-mediated translocation of a subfraction (but not all) of the p85 protein to the nucleus could enhance PI3K signaling. PMID: 24657164
15. No evidence for breast cancer susceptibility is associated with variants of BRD7. PMID: 22864638
16. Data show a substantial proportion of germ-line mutations in triple-negative breast cancer (TNBC), with a preponderance of BRCA1 mutations over mutations in BRCA2 or PALB2, but no evidence to implicate BRD7 mutations in the etiology of TNBC. PMID: 23110154
17. The region from aa219 to aa450 is primarily defined as an atypical nuclear export signal in BRD7. PMID: 21873788
18. Data indicate that BRD7 may be related to the occurrence, development, and metastasis of lung cancers. PMID: 22008115
19. miR-200c inhibits the expression of BRD7. MiR-200c regulated the translocation of beta-catenin from the cytoplasm to the nucleus via inhibition of BRD7, resulting in increased expression of its transcriptional target genes, cyclinD1 and c-myc. PMID: 22015043
20. All-trans retinoic acid enhances brd7 gene expression as HL-60 cells differentiate. PMID: 20561408
21. as unique regulators of replicative senescence in human cells, both BRD7 and BAF180 regulate p53 transcriptional activity toward a subset of its target genes required for replicative and oncogenic stress senescence induction PMID: 20660729
22. BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence. PMID: 20228809
23. Regulation of transcription by E1B-AP5 is mediated by complex formation with this protein. PMID: 12489984
24. BRD7 could up-regulate the expression levels of BRD2 and BRD3 genes in mRNA level to some extent. PMID: 12600283
25. Expression levels of NAG-7, and BRD7 did not alter in gastric and colorectal cancers. NAG-7 and BRD7 genes may not play role in gastric and colorectal carcinogenesis. PMID: 12918109
26. BRD7 inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. PMID: 15137061
27. Taken together, the present work shed light on the fact that a novel bromodomain gene, BRD7, is of importance in transcriptional regulation and cellular events including cell cycle. PMID: 16265664
28. the nuclear localization of BRD7 is critical for the expression of cell cycle related molecules and cell biological function. PMID: 16475162
29. The results showed that BRD7 could interact with BRD2 and the region from amino acid 430 to 798 of BRD2 was critical for the interaction of BRD2 with BRD7. BRD2 mainly localizes in nucleus and BRD2 has distinct roles in initiating apoptosis. PMID: 16786191
30. BRD7 promoter demethylation is a prerequisite for high level induction of BRD7 gene expression in human nasopharyngeal carcinoma cells PMID: 18778484
31. BRD7 is a novel PBAF-specific SWI/SNF subunit that is required for target gene activation and repression in embryonic stem cells PMID: 18809673
32. c-Myc negatively regulates and Sp1 slightly positively regulate BRD7 promoter activity. PMID: 19111069
顯示更多

收起更多
亞細(xì)胞定位：

[Isoform 2]: Nucleus.
數(shù)據(jù)庫鏈接：

HGNC: 14310

KEGG: hsa:29117

STRING: 9606.ENSP00000378181

UniGene: Hs.437894

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human